The partnership is established to serve Egypt’s healthcare framework will empower the Egyptian Drug Authority to monitor and ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Lightweight wrestlers from Harbor Creek and Fort LeBoeuf won the latest Erie Times-News athlete of the week polls.

UNR School of Medicine, along with Renown Medical Center, and Western Emergency Physicians form a Department of Emergency ...

Whooping cough and Norovirus cases continue rising every year post-pandemic, and some local doctors have a few guesses as to ...

Kentucky has issued its first medical marijuana patient cards. Gov. Andy Beshear presented the cards to Dr. Ryan Grell and Merissa Khumalo on Thursday. They are two of 2,200 Kentuckians who have been ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.